Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Rony Avritscher is active.

Publication


Featured researches published by Rony Avritscher.


Seminars in Interventional Radiology | 2008

Percutaneous transhepatic portal vein embolization: rationale, technique, and outcomes.

Rony Avritscher; Thierry de Baere; Ravi Murthy; Frederic Deschamps; David C. Madoff

Portal vein embolization (PVE) is used to induce preoperative liver hypertrophy in patients with anticipated marginal future liver remnant (FLR) volumes who are otherwise potential candidates for resection. PVE can be performed utilizing the transhepatic contralateral and ipsilateral approaches. The transhepatic contralateral approach is the most commonly used technique worldwide, largely owing to its technical ease. However, the contralateral approach risks injuring the FLR, thereby compromising the planned surgical resection. The transhepatic ipsilateral approach offers a potentially safer alternative because the complications associated with this approach affect only the hepatic lobe that will be resected and are usually not serious enough to preclude surgery. This article discusses PVE using the transhepatic ipsilateral and contralateral approaches, including patient selection criteria, anatomical and technical considerations, and patient complications and outcomes.


Journal of Vascular and Interventional Radiology | 2012

Temporary Balloon Occlusion of the Common Hepatic Artery for Administration of Yttrium-90 Resin Microspheres in a Patient with Patent Hepatoenteric Collaterals

Armeen Mahvash; Navid Zaer; Colette M. Shaw; Beth Chasen; Rony Avritscher; Ravi Murthy

The most common serious complication of yttrium-90 ((90)Y) therapy is gastrointestinal ulceration caused by extrahepatic microsphere dispersion. The authors describe the use of a balloon catheter for temporary occlusion of the common hepatic artery to reverse hepatoenteric flow for lobar administration of resin microspheres when coil embolization of a retroportal artery was impossible. At 9 months after treatment, the patient had no gastrointestinal side effects and showed a partial response.


Hematology-oncology Clinics of North America | 2009

Gastrointestinal stromal tumor: role of interventional radiology in diagnosis and treatment.

Rony Avritscher; Sanjay Gupta

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasm of the gastrointestinal tract. The interventional radiologist plays an important role in the diagnosis and locoregional therapy for metastatic GISTs. Radiofrequency ablation (RFA) is a potentially curative option for patients exhibiting partial response to imatinib with focal residual disease. RFA can also be used for local control of focal hepatic or peritoneal metastasis. Hepatic embolization or chemoembolization is reserved for the treatment of progressive liver disease in imatinib-resistant patients who are not suitable for sunitinib as a second-line therapy.


Radiology | 2014

Irreversible Electroporation of the Lumbar Vertebrae in a Porcine Model: Is There Clinical-Pathologic Evidence of Neural Toxicity?

A. Tam; Mohamed E. Abdelsalam; Mihai Gagea; Joe E. Ensor; Marwan Moussa; Muneeb Ahmed; S. Nahum Goldberg; K. Dixon; Amanda McWatters; Jennifer J. Miller; Govindarajan Srimathveeravalli; Stephen B. Solomon; Rony Avritscher; Michael J. Wallace; Sanjay Gupta

PURPOSE To evaluate the effects of irreversible electroporation (IRE) in the porcine spine. MATERIALS AND METHODS This study was approved by the institutional animal care and use committee. Twenty computed tomographically guided IRE ablations in either a transpedicular location or directly over the posterior cortex were performed in the lumbar vertebrae of 10 pigs by a single operator. T1- and T2-weighted magnetic resonance (MR) imaging was performed with and without contrast material 2 or 7 days after ablation. Mathematical modeling was performed to estimate the extent of ablation. Clinical, radiologic, pathologic, and simulation findings were analyzed. The Miller low-bias back transformation was used to construct 95% confidence intervals for the mean absolute percentage difference between the maximum length and width of the ablation zone on MR images and pathologic measurements by using square-root-transformed data. RESULTS Bipolar IRE electrode placement and ablation were successful in all cases. The mean distances from the IRE electrode to the posterior wall of the vertebral body or the exiting nerve root were 2.93 mm ± 0.77 (standard deviation) and 7.87 mm ± 1.99, respectively. None of the animals had neurologic deficits. Well-delineated areas of necrosis of bone, bone marrow, and skeletal muscle adjacent to the vertebral body were present. Histopathologic changes showed outcomes that matched with simulation-estimated ablation zones. The percentage absolute differences in the ablation measurements between MR imaging and histopathologic examination showed the following average errors: 24.2% for length and 28.8% for width measurements on T2-weighted images, and 26.1% for length and 33.3% for width measurements on T1-weighted contrast material-enhanced images. CONCLUSION IRE ablation in the porcine spine is feasible and safe and produces localized necrosis with minimal neural toxicity. Signal intensity changes on images acquired with standard MR imaging sequences demonstrate the ablation zone to be larger than that at histopathologic examination.


Expert Review of Gastroenterology & Hepatology | 2010

Portal vein embolization: rationale, outcomes, controversies and future directions.

Rony Avritscher; Eugene Duke; David C. Madoff

Portal vein embolization (PVE) is now considered the standard of care to improve safety for patients undergoing extensive hepatectomy with an anticipated small future liver remnant (FLR). PVE is used to induce contralateral liver hypertrophy in preparation for major liver resection. Optimal patient selection is essential to maximize the clinical benefits of PVE. Computed tomography volumetry is used to calculate a standardized FLR and determine the need for preoperative PVE. Percutaneous PVE can be performed via the transhepatic ipsilateral or contralateral approaches, depending on operator preference. Several different embolic agents are available to the interventional radiologist, all with similar effectiveness in inducing hypertrophy. When an extended hepatectomy is planned, right PVE should include segment 4, in order to maximize FLR hypertrophy. Multiple studies have demonstrated the beneficial outcomes of PVE in both patients with healthy livers and with underlying liver diseases. Novel improvements to PVE should expand its scope to patients who were previously not candidates for the procedure.


Journal of Vascular and Interventional Radiology | 2011

Development of a large animal model of cirrhosis and portal hypertension using hepatic transarterial embolization: A study in swine

Rony Avritscher; Kenneth C. Wright; Sanaz Javadi; Rajesh Uthamanthil; Sanjay Gupta; Mihai Gagea; Roland L. Bassett; Ravi Murthy; Michael J. Wallace; David C. Madoff

PURPOSE To develop a clinically relevant porcine model of liver cirrhosis with portal hypertension by means of hepatic transarterial embolization. MATERIALS AND METHODS Institutional animal care and use committee approval was obtained for all experiments. Pigs received transcatheter arterial infusion of a 3:1 mixture of iodized oil and ethanol into the hepatic artery in volumes of 16 mL in group 1 (n = 4), 28 mL in group 2 (n = 4), and 40 mL in group 3 (n = 4) with intent of bilobar distribution. Hepatic venous pressure gradient (HVPG) measurement, liver function tests, and volumetry were performed at baseline, at 2 weeks, and before necropsy. RESULTS Cirrhosis was successfully induced in three animals that received 16 mL of the embolic mixture and in all four animals that received 28 mL. The animals in the 40-mL group did not recover from the procedure and were euthanized within 48 h. Increases in HVPG after 6-8 weeks versus baseline reached statistical significance (P < .05). Correlation between degree of fibrosis and volume of embolic agent did not reach statistical significance, but there was a trend toward increased fibrosis in the 28-mL group compared with the 16-mL group. CONCLUSIONS Transcatheter hepatic arterial embolization can be used to create a reliable and reproducible porcine model of liver cirrhosis and portal hypertension.


Cancer | 2010

Accuracy and sensitivity of computed tomography-guided percutaneous needle biopsy of pulmonary hilar lymph nodes.

Rony Avritscher; Savitri Krishnamurthy; Joe Ensor; Sanjay Gupta; Alda L. Tam; David C. Madoff; Ravi Murthy; Marshall E. Hicks; Michael J. Wallace

Because of their proximity to the pulmonary artery or vein, hilar lymph nodes are routinely biopsied with endobronchial or endoscopic ultrasonography (EUS)‐guided fine‐needle aspiration biopsy (FNAB). Computed tomography (CT)‐guided percutaneous needle biopsy (PNB) allows the operator to acquire a larger core needle biopsy (CNB) when initial samples are inconclusive, when the suspected disease is not optimally diagnosed with FNAB, or when biomarkers are required. The purpose of this study was to retrospectively evaluate the sensitivity and accuracy of CT‐guided PNB in patients with hilar adenopathy.


Journal of Magnetic Resonance Imaging | 2014

Evaluation of liver fibrosis and hepatic venous pressure gradient with MR elastography in a novel swine model of cirrhosis

Steven Y. Huang; Mohamed Abdelsalam; Samer Harmoush; Joe E. Ensor; Justin Chetta; Ken Pin Hwang; R. Jason Stafford; David C. Madoff; Rony Avritscher

To assess the correlation among MR elastography (MRE) measured liver stiffness (LS), liver fibrosis, and hepatic venous pressure gradient (HVPG) in a swine model of cirrhosis.


Acta Radiologica | 2013

Gastroduodenal artery recanalization after transcatheter fibered coil embolization for prevention of hepaticoenteric flow: incidence and predisposing technical factors in 142 patients.

Jose Enriquez; Sanaz Javadi; Ravi Murthy; Joe Ensor; Armeen Mahvash; Mohamed Abdelsalam; David C. Madoff; Michael J. Wallace; Rony Avritscher

Background Prophylactic occlusion of extrahepatic vessels prior to radioembolization or chemotherapy infusion is an effective method to prevent gastrointestinal complications. Unfortunately, vascular recanalization can occur. Purpose To retrospectively determine the rate and technical factors associated with gastroduodenal artery (GDA) recanalization after transcatheter occlusion with fibered coils. Material and Methods Patients with hepatic malignancy who underwent fibered coil occlusion of the GDA origin for radioembolization or hepatic arterial chemotherapy infusion with at least one subsequent hepatic angiogram between March 2006 and January 2011 were included. One hundred and forty-two patients (men, 71; women, 71) met study criteria. Hepatic arteriograms were reviewed to determine the frequency of arterial recanalization. Additional parameters included: patients’ demographics, GDA diameter, length of coil pack, distance between GDA origin and most cephalad coil, persistent flow at the conclusion of the initial GDA occlusion procedure, platelet count, and international normalized ratio (INR). Chi-square test and pooled t-test were used to compare the two groups. Prospective multivariate analysis was performed with a logistic regression model. Results Twenty-nine of 142 patients (20.4%) experienced GDA recanalization. The distance between the GDA origin and most cephalad coil was significantly greater in the recanalization group than in the non-recanalization group (9.6 mm vs. 12.6 mm, P = 0.01). A prospective multivariate analysis established that the further the coil was from the origin the more likely the GDA was to recanalize. The two groups did not differ on the basis of any other factors examined. Conclusion GDA origin recanalization after fibered coil occlusion is common. The distance between the GDA origin and most cephalad coil appears to be a predisposing factor for recanalization. Familiarity with this phenomenon is beneficial to reduce the likelihood of gastrointestinal tract complications during hepatic locoregional therapy.


Oncology | 2016

Validation of a Preclinical Model of Diethylnitrosamine-Induced Hepatic Neoplasia in Yucatan Miniature Pigs

Jennifer Mitchell; Peggy T. Tinkey; Rony Avritscher; Carolyn S. Van Pelt; Ghazaleh Eskandari; Suraj K. George; Lianchun Xiao; Erik Cressman; Jeffrey S. Morris; Asif Rashid; Ahmed Kaseb; Hesham M. Amin; Rajesh Uthamanthil

Objective: The purpose of this study was to reduce the time to tumor onset in a diethylnitrosamine (DEN)-induced hepatocellular carcinoma (HCC) swine model via partial liver embolization (PLE) and to characterize the model for use in translational research. Methods: Eight Yucatan miniature pigs were injected intraperitoneally with either saline (n = 2) or DEN (n = 6) solution weekly for 12 weeks. Three of the DEN-treated pigs underwent PLE. The animals underwent periodic radiological evaluation, liver biopsy, and blood sampling, and full necropsy was performed at study termination (∼29 months). Results: All DEN-treated pigs developed hepatic adenoma and HCC. PLE accelerated the time to adenoma development but not to HCC development. Biomarker analysis results showed that IGF1 levels decreased in all DEN-treated pigs as functional liver capacity decreased with progression of HCC. VEGF and IL-6 levels were positively correlated with disease progression. Immunohistochemical probing of HCC tissues demonstrated the expression of several important survival-promoting proteins. Conclusion: To our knowledge, we are the first to demonstrate an accelerated development of hepatic neoplasia in Yucatan miniature pigs. Our HCC swine model closely mimics the human condition (i.e., progressive disease stages and expression of relevant molecular markers) and is a viable translational model.

Collaboration


Dive into the Rony Avritscher's collaboration.

Top Co-Authors

Avatar

Michael J. Wallace

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Ravi Murthy

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Armeen Mahvash

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Bruno C. Odisio

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Sanjay Gupta

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Joe E. Ensor

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

A. Tam

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Mohamed E. Abdelsalam

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

Beth Chasen

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors

Avatar

K. Dixon

University of Texas MD Anderson Cancer Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge